GB9325445D0
(en)
|
1993-12-13 |
1994-02-16 |
Cortecs Ltd |
Pharmaceutical formulations
|
CN1183715A
(zh)
|
1995-05-09 |
1998-06-03 |
科洛康有限公司 |
适合药物基质静电包衣的粉末包衣物质
|
US7008668B2
(en)
|
1995-05-09 |
2006-03-07 |
Phoqus Pharmaceuticals Limited |
Powder coating composition for electrostatic coating of pharmaceutical substrates
|
US5750147A
(en)
*
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
HU227745B1
(en)
*
|
1996-05-20 |
2012-02-28 |
Janssen Pharmaceutica Nv |
Antifungal compositions containing itraconazole
|
US5846971A
(en)
*
|
1996-06-28 |
1998-12-08 |
Schering Corporation |
Oral antifungal composition
|
JP2000514059A
(ja)
*
|
1996-06-28 |
2000-10-24 |
シェーリング コーポレイション |
トリアゾール抗真菌化合物を含む経口組成物
|
GB9623634D0
(en)
|
1996-11-13 |
1997-01-08 |
Bpsi Holdings Inc |
Method and apparatus for the coating of substrates for pharmaceutical use
|
FR2758459B1
(fr)
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
BR9806174A
(pt)
*
|
1997-03-26 |
1999-10-19 |
Janssen Pharmaceutica Nv |
Péletes tendo um núcleo revestido com um antifúngico e um polìmero
|
KR19990001564A
(ko)
*
|
1997-06-16 |
1999-01-15 |
유충식 |
용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
|
DE69808670T2
(de)
*
|
1997-12-31 |
2003-07-03 |
Choongwae Pharma Corp., Seoul/Soul |
Herstellungsverfahren und zusammensetzung einer oralen zubereitung von itraconazol
|
KR100514330B1
(ko)
*
|
1997-12-31 |
2006-02-17 |
주식회사 중외제약 |
난용성 약물을 함유하는 코팅정
|
DE19808634A1
(de)
*
|
1998-02-24 |
1999-08-26 |
Schering Ag |
Mantel für eine pharmazeutische Zusammensetzung
|
UA65607C2
(uk)
|
1998-03-04 |
2004-04-15 |
Орто-Макнейл Фармацевтикал, Інк. |
Фармацевтична композиція (варіанти) та спосіб її приготування
|
TR200002217T2
(tr)
|
1998-07-17 |
2001-02-21 |
Janssen Pharmaceutica N.V. |
Bir mantar ilacı ve bir polimer ile kaplanmış bir çekirdeğe sahip taneler.
|
ES2157731B1
(es)
*
|
1998-07-21 |
2002-05-01 |
Liconsa Liberacion Controlada |
Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
JP2003531099A
(ja)
|
1999-03-24 |
2003-10-21 |
エフ エム シー コーポレーション |
改良された水溶解度をもつ医薬製剤
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US20060034937A1
(en)
*
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
KR100694667B1
(ko)
*
|
1999-12-08 |
2007-03-14 |
동아제약주식회사 |
생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
|
JP5159012B2
(ja)
*
|
1999-12-23 |
2013-03-06 |
メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド |
不良溶解性の薬物に対する改良された医薬組成物
|
CN101385732A
(zh)
*
|
2000-02-29 |
2009-03-18 |
布里斯托尔-迈尔斯斯奎布公司 |
低剂量艾替开韦制剂及其应用
|
US6551608B2
(en)
*
|
2000-03-06 |
2003-04-22 |
Porex Technologies Corporation |
Porous plastic media with antiviral or antimicrobial properties and processes for making the same
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US6673373B2
(en)
*
|
2001-02-01 |
2004-01-06 |
Carlsbad Technology Inc. |
Antifungal formulation and the methods for manufacturing and using the same
|
US6663897B2
(en)
*
|
2001-02-06 |
2003-12-16 |
Dsm Ip Assets B.V. |
Oral itraconazole formulations and methods of making the same
|
CN100369904C
(zh)
|
2001-02-14 |
2008-02-20 |
泰博特克药品有限公司 |
2-(取代-氨基)-苯并噻唑磺酰胺hiv蛋白酶抑制剂
|
AR035819A1
(es)
|
2001-04-09 |
2004-07-14 |
Tibotec Pharm Ltd |
2-(amino sustituido)-benzoxazol sulfonamidas, inhibidoras de la proteasa del hiv, composiciones farmaceuticas que comprenden dichos compuestos, metodo in vitro para inhibir la replicacion retroviral y uso de dichos compuestos en la fabricacion de medicamentos
|
PT1387842E
(pt)
|
2001-05-11 |
2009-07-20 |
Tibotec Pharm Ltd |
2-aminobenzoxazolsulfonamidas inibidoras de largo espectro da protease hiv
|
US20030070584A1
(en)
*
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
AU4061702A
(en)
*
|
2001-05-15 |
2003-04-03 |
Mcneil-Ppc, Inc. |
Dip coating compositions containing starch or dextrin
|
KR100438485B1
(ko)
*
|
2001-08-13 |
2004-07-09 |
한국디디에스제약 주식회사 |
아졸류 항진균제의 약제학적 조성물
|
US8071133B2
(en)
|
2001-08-20 |
2011-12-06 |
Stiefel Laboratories, Inc. |
Oral dosage forms of water insoluble drugs and methods of making the same
|
US8309118B2
(en)
*
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
CA2363376A1
(en)
*
|
2001-11-16 |
2003-05-16 |
Bernard Charles Sherman |
Solid pharmaceutical compositions for oral administration comprising itraconazole
|
EP1463502B1
(en)
|
2001-12-21 |
2011-07-13 |
Tibotec Pharmaceuticals |
Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
|
US7078526B2
(en)
*
|
2002-05-31 |
2006-07-18 |
Transform Pharmaceuticals, Inc. |
CIS-itraconazole crystalline forms and related processes, pharmaceutical compositions and methods
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
US7446107B2
(en)
*
|
2002-02-15 |
2008-11-04 |
Transform Pharmaceuticals, Inc. |
Crystalline forms of conazoles and methods of making and using the same
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
CA2477923C
(en)
*
|
2002-03-01 |
2021-02-23 |
University Of South Florida |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
MY142238A
(en)
|
2002-03-12 |
2010-11-15 |
Tibotec Pharm Ltd |
Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
|
SI1517899T1
(sl)
|
2002-05-17 |
2008-02-29 |
Tibotec Pharm Ltd |
Substituirani benzoksazol sulfonamidi sirokega spektra, ki so HIV proteazni inhibitorji
|
US20070059356A1
(en)
*
|
2002-05-31 |
2007-03-15 |
Almarsson Oern |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
MXPA05000232A
(es)
*
|
2002-06-21 |
2005-06-17 |
Transform Pharmaceuticals Inc |
Composiciones farmaceuticas con disolucion mejorada.
|
EP1542728A4
(en)
*
|
2002-07-22 |
2005-09-21 |
Nanohybrid Co Ltd |
HYBRID OF ITRACONAZOLE, CYCLOSPORINE OR CARVEDILOL WITH A LAYERED SILICATE AND PROCESS FOR PREPARING THE SAME
|
US7429619B2
(en)
*
|
2002-08-02 |
2008-09-30 |
Mcneil Consumer Healthcare |
Polyacrylic film forming compositions
|
KR100994759B1
(ko)
|
2002-08-14 |
2010-11-16 |
티보텍 파마슈티컬즈 |
광역스펙트럼의 치환된 옥신돌 설폰아미드 hiv프로테아제 저해제
|
US20040086567A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Pawan Seth |
Bioequivalent composition of itraconazole and a hydrophilic polymer
|
AU2002352938B8
(en)
|
2002-11-26 |
2009-10-08 |
The University Of Chicago |
Materials and methods for preventing and treating microbe-mediated epithelial disorders
|
US8183290B2
(en)
*
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
EP1438960B2
(en)
*
|
2003-01-14 |
2012-12-19 |
Acino Pharma AG |
Compostion of itraconazole dispersed in a hydrophilic polymer having enhanced bioavailability
|
DK1438961T4
(da)
†
|
2003-01-14 |
2014-11-17 |
Acino Pharma Ag |
Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
|
FR2852607B1
(fr)
*
|
2003-03-20 |
2006-07-14 |
|
Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
|
WO2005023242A1
(en)
|
2003-09-11 |
2005-03-17 |
Tibotec Pharmaceuticals Ltd. |
Entry inhibitors of the hiv virus
|
US20050074494A1
(en)
*
|
2003-10-06 |
2005-04-07 |
Xiu-Xiu Cheng |
Itraconazole immediate release formulation
|
US20050118265A1
(en)
*
|
2003-11-28 |
2005-06-02 |
Anandi Krishnan |
Antifungal oral dosage forms and the methods for preparation
|
US9247765B2
(en)
|
2004-01-14 |
2016-02-02 |
Omniactive Health Technologies Limited |
Stable beadlets of lipophilic nutrients
|
US20050249799A1
(en)
*
|
2004-03-03 |
2005-11-10 |
Spherics, Inc. |
Polymeric drug delivery system for hydrophobic drugs
|
AR048650A1
(es)
|
2004-05-04 |
2006-05-10 |
Tibotec Pharm Ltd |
Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
|
AU2005244121B2
(en)
|
2004-05-07 |
2012-01-19 |
Sequoia Pharmaceuticals, Inc. |
Resistance-repellent retroviral protease inhibitors
|
JP4879889B2
(ja)
|
2004-05-17 |
2012-02-22 |
テイボテク・フアーマシユーチカルズ・リミテツド |
4−置換−1,5−ジヒドロ−ピリド[3,2−b]インドール−2−オン
|
CN1976930B
(zh)
|
2004-05-17 |
2011-01-19 |
泰博特克药品有限公司 |
用作抗感染药物的6,7,8,9-取代的1-苯基-1,5-二氢吡啶并(3,2-b)吲哚-2-酮
|
EA012330B1
(ru)
|
2004-05-17 |
2009-08-28 |
Тиботек Фармасьютикалз Лтд. |
1-ГЕТЕРОЦИКЛИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ
|
WO2006026504A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Mucoadhesive oral formulations of high permeability, high solubility drugs
|
US20060045865A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
US20100297251A1
(en)
*
|
2004-09-01 |
2010-11-25 |
Board Of Regents, The University Of Texas System |
Encapsulated particles for enteric release
|
US20100297248A1
(en)
*
|
2004-09-01 |
2010-11-25 |
Board Of Regents, The University Of Texas System |
Encapsulated particles for amorphous stability enhancement
|
US20060045822A1
(en)
|
2004-09-01 |
2006-03-02 |
Board Of Regents, The University Of Texas System |
Plasma polymerization for encapsulating particles
|
FR2883179B1
(fr)
|
2005-03-18 |
2009-04-17 |
Ethypharm Sa |
Comprime enrobe
|
TW200710091A
(en)
|
2005-04-11 |
2007-03-16 |
Tibotec Pharm Ltd |
(1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
|
JP2009502258A
(ja)
*
|
2005-07-21 |
2009-01-29 |
ノミール・メディカル・テクノロジーズ・インコーポレーテッド |
標的部位の生物学的汚染物質のレベルを下げる方法
|
US20070148240A1
(en)
*
|
2005-12-23 |
2007-06-28 |
Fang-Yu Lee |
Oral formulation containing itraconazole and methods for manufacturing and using the same
|
WO2007113290A1
(en)
|
2006-04-03 |
2007-10-11 |
Tibotec Pharmaceuticals Ltd. |
Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
|
CN101091725A
(zh)
*
|
2006-06-23 |
2007-12-26 |
天津天士力制药股份有限公司 |
一种中药颗粒及其制备方法
|
US20100151035A1
(en)
*
|
2007-03-13 |
2010-06-17 |
Sandoz Ag |
Pharmaceutical compositions of poorly soluble drugs
|
CN101283984B
(zh)
*
|
2007-04-12 |
2010-05-26 |
永胜药品工业股份有限公司 |
高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
|
US7314641B1
(en)
|
2007-04-18 |
2008-01-01 |
Everest Pharm. Industrial Co., Ltd. |
High-bioavailability particle coated with fungicide and polymer
|
JP2008280254A
(ja)
*
|
2007-05-08 |
2008-11-20 |
Everest Pharm Industrial Co Ltd |
生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
|
EP2224923A4
(en)
|
2007-11-28 |
2013-05-15 |
Sequoia Pharmaceuticals Inc |
COMPOSITIONS AND METHOD FOR INHIBITING ZYTOCHROM P450 2D6
|
US8906647B2
(en)
|
2008-02-21 |
2014-12-09 |
Sequoia Pharmaceuticals, Inc. |
Diamide inhibitors of cytochrome P450
|
WO2009114834A2
(en)
|
2008-03-13 |
2009-09-17 |
Board Of Regents, The University Of Texas System |
Covalently functionalized particles for synthesis of new composite materials
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
SG174658A1
(en)
|
2010-04-01 |
2011-10-28 |
Theravida Inc |
Pharmaceutical formulations for the treatment of overactive bladder
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
BR112013015085A8
(pt)
*
|
2010-12-16 |
2018-04-03 |
Univ Texas |
Composição farmacêutica, método para preparar uma composição, e, uso de composição
|
US8940763B2
(en)
|
2011-05-10 |
2015-01-27 |
Theravida, Inc. |
Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
|
WO2013192566A1
(en)
|
2012-06-21 |
2013-12-27 |
Mayne Pharma International Pty. Ltd. |
Itraconazole compositions and dosage forms, and methods of using the same
|
CN103948911B
(zh)
*
|
2014-04-23 |
2016-04-20 |
深圳市健元医药科技有限公司 |
一种棘白菌素类抗真菌药物缓释微球制剂及其制备方法
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
AU2016388308B2
(en)
|
2016-01-20 |
2022-08-04 |
Theravida, Inc. |
Methods and compositions for treating hyperhidrosis
|
EP3544614A4
(en)
|
2016-11-28 |
2020-08-05 |
Lipocine Inc. |
ORAL TESTOSTERONE UNDECANOATE THERAPY
|